Astrazeneca Pharma India Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 744.22 | 692.02 | 584.56 |
| Operating Expense | 648.49 | 634.09 | 518.78 |
| Net Profit | 62.33 | 37.93 | 44.88 |
| Net Profit Margin | 8.38% | 5.48% | 7.68% |
| Earning Per Share | 24.93 | 15.17 | 17.95 |
| EBIDTA | 94.60 | 55.98 | 66.83 |
| Effective Tax Rate | 26.15% | 18.76% | 21.75% |
Particulars
Sep 2026
Revenue744.22
Operating Expense648.49
Net Profit62.33
Net Profit Margin8.38
Earning Per Share24.93
EBIDTA94.60
Effective Tax Rate26.15
